

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 5.42393580 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 5.42393580 |
| 3 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.29961000 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 5.26218633 |
| 5 | L-phenylalanine metabolic process (GO:0006558) | 5.26218633 |
| 6 | response to peptidoglycan (GO:0032494) | 4.92464897 |
| 7 | aromatic amino acid family catabolic process (GO:0009074) | 4.92359445 |
| 8 | neutrophil activation involved in immune response (GO:0002283) | 4.69127860 |
| 9 | glycosphingolipid catabolic process (GO:0046479) | 4.63285517 |
| 10 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.62135463 |
| 11 | protein carboxylation (GO:0018214) | 4.62135463 |
| 12 | cysteine metabolic process (GO:0006534) | 4.61075646 |
| 13 | cellular response to thyroid hormone stimulus (GO:0097067) | 4.61066555 |
| 14 | indole-containing compound catabolic process (GO:0042436) | 4.48740372 |
| 15 | indolalkylamine catabolic process (GO:0046218) | 4.48740372 |
| 16 | tryptophan catabolic process (GO:0006569) | 4.48740372 |
| 17 | bile acid biosynthetic process (GO:0006699) | 4.46603724 |
| 18 | alpha-linolenic acid metabolic process (GO:0036109) | 4.39904317 |
| 19 | oligosaccharide catabolic process (GO:0009313) | 4.38821374 |
| 20 | high-density lipoprotein particle remodeling (GO:0034375) | 4.35543206 |
| 21 | kynurenine metabolic process (GO:0070189) | 4.35527332 |
| 22 | negative regulation of interleukin-12 production (GO:0032695) | 4.35359381 |
| 23 | urea metabolic process (GO:0019627) | 4.33504881 |
| 24 | urea cycle (GO:0000050) | 4.33504881 |
| 25 | tryptophan metabolic process (GO:0006568) | 4.32762209 |
| 26 | glyoxylate metabolic process (GO:0046487) | 4.25862943 |
| 27 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.25224792 |
| 28 | complement activation, alternative pathway (GO:0006957) | 4.24830067 |
| 29 | sulfur amino acid catabolic process (GO:0000098) | 4.18567380 |
| 30 | glycolipid catabolic process (GO:0019377) | 4.17937837 |
| 31 | regulation of protein activation cascade (GO:2000257) | 4.13143289 |
| 32 | plasma lipoprotein particle clearance (GO:0034381) | 4.05351280 |
| 33 | plasma lipoprotein particle remodeling (GO:0034369) | 4.04230805 |
| 34 | protein-lipid complex remodeling (GO:0034368) | 4.04230805 |
| 35 | macromolecular complex remodeling (GO:0034367) | 4.04230805 |
| 36 | nitrogen cycle metabolic process (GO:0071941) | 4.02487573 |
| 37 | negative regulation of fibrinolysis (GO:0051918) | 4.00482435 |
| 38 | regulation of cholesterol esterification (GO:0010872) | 3.98165361 |
| 39 | phospholipid efflux (GO:0033700) | 3.94113763 |
| 40 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.92096891 |
| 41 | regulation of complement activation (GO:0030449) | 3.91207268 |
| 42 | reverse cholesterol transport (GO:0043691) | 3.90973512 |
| 43 | response to thyroid hormone (GO:0097066) | 3.85868614 |
| 44 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.84827882 |
| 45 | bile acid metabolic process (GO:0008206) | 3.83164893 |
| 46 | regulation of triglyceride catabolic process (GO:0010896) | 3.83137576 |
| 47 | amino-acid betaine metabolic process (GO:0006577) | 3.82247020 |
| 48 | regulation of fibrinolysis (GO:0051917) | 3.81875647 |
| 49 | aldehyde catabolic process (GO:0046185) | 3.77999160 |
| 50 | regulation of mononuclear cell migration (GO:0071675) | 3.76612000 |
| 51 | lysine metabolic process (GO:0006553) | 3.73940271 |
| 52 | lysine catabolic process (GO:0006554) | 3.73940271 |
| 53 | plasma lipoprotein particle assembly (GO:0034377) | 3.73299486 |
| 54 | ceramide catabolic process (GO:0046514) | 3.67298741 |
| 55 | low-density lipoprotein particle remodeling (GO:0034374) | 3.66407553 |
| 56 | cholesterol efflux (GO:0033344) | 3.64729414 |
| 57 | homocysteine metabolic process (GO:0050667) | 3.60955510 |
| 58 | aromatic amino acid family metabolic process (GO:0009072) | 3.56064504 |
| 59 | cofactor catabolic process (GO:0051187) | 3.53836317 |
| 60 | macrophage activation involved in immune response (GO:0002281) | 3.53315594 |
| 61 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.51835348 |
| 62 | T-helper 1 type immune response (GO:0042088) | 3.51224554 |
| 63 | serine family amino acid catabolic process (GO:0009071) | 3.48431946 |
| 64 | blood coagulation, intrinsic pathway (GO:0007597) | 3.47683335 |
| 65 | immunoglobulin mediated immune response (GO:0016064) | 3.46253669 |
| 66 | plasma lipoprotein particle organization (GO:0071827) | 3.45243044 |
| 67 | regulation of vitamin D biosynthetic process (GO:0060556) | 3.43797612 |
| 68 | triglyceride homeostasis (GO:0070328) | 3.43683908 |
| 69 | acylglycerol homeostasis (GO:0055090) | 3.43683908 |
| 70 | protein-lipid complex assembly (GO:0065005) | 3.41506931 |
| 71 | tyrosine metabolic process (GO:0006570) | 3.41467414 |
| 72 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.40511162 |
| 73 | amino sugar catabolic process (GO:0046348) | 3.39644638 |
| 74 | negative regulation of sterol transport (GO:0032372) | 3.36934927 |
| 75 | negative regulation of cholesterol transport (GO:0032375) | 3.36934927 |
| 76 | bile acid and bile salt transport (GO:0015721) | 3.33573599 |
| 77 | ethanol oxidation (GO:0006069) | 3.33014764 |
| 78 | fibrinolysis (GO:0042730) | 3.31792726 |
| 79 | protein-lipid complex subunit organization (GO:0071825) | 3.28592944 |
| 80 | phospholipid homeostasis (GO:0055091) | 3.27698182 |
| 81 | alpha-amino acid catabolic process (GO:1901606) | 3.27151061 |
| 82 | regulation of mast cell degranulation (GO:0043304) | 3.25456595 |
| 83 | imidazole-containing compound metabolic process (GO:0052803) | 3.23637251 |
| 84 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.20867539 |
| 85 | indolalkylamine metabolic process (GO:0006586) | 3.20013650 |
| 86 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 3.19684303 |
| 87 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 3.19684303 |
| 88 | detection of molecule of bacterial origin (GO:0032490) | 3.18766195 |
| 89 | cellular glucuronidation (GO:0052695) | 3.18543426 |
| 90 | glycine metabolic process (GO:0006544) | 3.17969201 |
| 91 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 3.17314382 |
| 92 | protein activation cascade (GO:0072376) | 3.16920634 |
| 93 | amine catabolic process (GO:0009310) | 3.15929649 |
| 94 | cellular biogenic amine catabolic process (GO:0042402) | 3.15929649 |
| 95 | response to nitrosative stress (GO:0051409) | 3.14979515 |
| 96 | regulation of cholesterol storage (GO:0010885) | 3.14364185 |
| 97 | benzene-containing compound metabolic process (GO:0042537) | 3.13173490 |
| 98 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.11538575 |
| 99 | carnitine metabolic process (GO:0009437) | 3.10571424 |
| 100 | valine metabolic process (GO:0006573) | 3.10179904 |
| 101 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.09328400 |
| 102 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.09328400 |
| 103 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.08748618 |
| 104 | serine family amino acid metabolic process (GO:0009069) | 3.08229380 |
| 105 | positive regulation by symbiont of host defense response (GO:0052509) | 3.08088102 |
| 106 | modulation by symbiont of host defense response (GO:0052031) | 3.08088102 |
| 107 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.08088102 |
| 108 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.08088102 |
| 109 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.08088102 |
| 110 | modulation by symbiont of host immune response (GO:0052553) | 3.08088102 |
| 111 | positive regulation of leukocyte degranulation (GO:0043302) | 3.05698501 |
| 112 | cellular modified amino acid catabolic process (GO:0042219) | 3.05274236 |
| 113 | regulation of macrophage chemotaxis (GO:0010758) | 3.05182989 |
| 114 | cholesterol homeostasis (GO:0042632) | 3.04364826 |
| 115 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 3.04155639 |
| 116 | positive regulation of chemokine biosynthetic process (GO:0045080) | 3.03612700 |
| 117 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 3.02577139 |
| 118 | pyridine nucleotide biosynthetic process (GO:0019363) | 3.02577139 |
| 119 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.02113277 |
| 120 | cellular amino acid catabolic process (GO:0009063) | 3.01996168 |
| 121 | cellular ketone body metabolic process (GO:0046950) | 3.01890304 |
| 122 | protoporphyrinogen IX metabolic process (GO:0046501) | 3.01840264 |
| 123 | acute-phase response (GO:0006953) | 3.01406441 |
| 124 | regulation of podosome assembly (GO:0071801) | 3.01385258 |
| 125 | complement activation (GO:0006956) | 3.00720190 |
| 126 | regulation of vitamin metabolic process (GO:0030656) | 3.00591245 |
| 127 | positive regulation of lipid catabolic process (GO:0050996) | 3.00214485 |
| 128 | sterol homeostasis (GO:0055092) | 3.00148059 |
| 129 | pinocytosis (GO:0006907) | 2.99739460 |
| 130 | detection of other organism (GO:0098543) | 2.99513227 |
| 131 | coenzyme catabolic process (GO:0009109) | 2.99058183 |
| 132 | complement activation, classical pathway (GO:0006958) | 2.99007581 |
| 133 | granulocyte activation (GO:0036230) | 2.98764934 |
| 134 | membrane lipid catabolic process (GO:0046466) | 2.98430358 |
| 135 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.98162537 |
| 136 | NAD biosynthetic process (GO:0009435) | 2.98142891 |
| 137 | glutamate metabolic process (GO:0006536) | 2.97443656 |
| 138 | low-density lipoprotein particle clearance (GO:0034383) | 2.97413322 |
| 139 | lipoprotein metabolic process (GO:0042157) | 2.96845712 |
| 140 | glucuronate metabolic process (GO:0019585) | 2.96655441 |
| 141 | regulation of leukocyte degranulation (GO:0043300) | 2.95773203 |
| 142 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.95331742 |
| 143 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.94337832 |
| 144 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.90658700 |
| 145 | positive regulation of mast cell degranulation (GO:0043306) | 2.90658700 |
| 146 | response to muramyl dipeptide (GO:0032495) | 2.88993350 |
| 147 | sphingolipid catabolic process (GO:0030149) | 2.88326166 |
| 148 | N-acetylneuraminate metabolic process (GO:0006054) | 2.87912503 |
| 149 | detection of external biotic stimulus (GO:0098581) | 2.87388608 |
| 150 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.82208353 |
| 151 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.81924961 |
| 152 | germinal center formation (GO:0002467) | 2.81196266 |
| 153 | adhesion of symbiont to host cell (GO:0044650) | 2.79267221 |
| 154 | virion attachment to host cell (GO:0019062) | 2.79267221 |
| 155 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.78035313 |
| 156 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.77836082 |
| 157 | positive regulation of mast cell activation (GO:0033005) | 2.75054330 |
| 158 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.74715249 |
| 159 | detection of bacterium (GO:0016045) | 2.73888246 |
| 160 | regulation of chemokine biosynthetic process (GO:0045073) | 2.73560443 |
| 161 | myeloid dendritic cell differentiation (GO:0043011) | 2.73317232 |
| 162 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.73094206 |
| 163 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.71154164 |
| 164 | regulation of cytokine secretion involved in immune response (GO:0002739) | 2.68864274 |
| 165 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 2.68655534 |
| 166 | adhesion of symbiont to host (GO:0044406) | 2.68555622 |
| 167 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.68329499 |
| 168 | positive regulation of cholesterol efflux (GO:0010875) | 2.68319599 |
| 169 | cellular response to arsenic-containing substance (GO:0071243) | 2.66720342 |
| 170 | regulation of interferon-alpha production (GO:0032647) | 2.66417759 |
| 171 | NIK/NF-kappaB signaling (GO:0038061) | 2.66195942 |
| 172 | fat-soluble vitamin biosynthetic process (GO:0042362) | 2.65528285 |
| 173 | negative regulation of lipid storage (GO:0010888) | 2.64784282 |
| 174 | myeloid cell activation involved in immune response (GO:0002275) | 2.63841122 |
| 175 | negative regulation of interleukin-17 production (GO:0032700) | 2.62852771 |
| 176 | cellular response to lipopolysaccharide (GO:0071222) | 2.61764090 |
| 177 | regulation of superoxide anion generation (GO:0032928) | 2.58859429 |
| 178 | positive regulation of antigen processing and presentation (GO:0002579) | 2.57780642 |
| 179 | barbed-end actin filament capping (GO:0051016) | 2.56021498 |
| 180 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 2.55217106 |
| 181 | macrophage activation (GO:0042116) | 2.55093850 |
| 182 | cellular response to molecule of bacterial origin (GO:0071219) | 2.53996730 |
| 183 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.53840681 |
| 184 | neutrophil activation (GO:0042119) | 2.53774864 |
| 185 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.52266904 |
| 186 | positive regulation of type 2 immune response (GO:0002830) | 2.52153856 |
| 187 | peptide catabolic process (GO:0043171) | 2.51933637 |
| 188 | response to protozoan (GO:0001562) | 2.51911088 |
| 189 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.50246234 |
| 190 | myeloid dendritic cell activation (GO:0001773) | 2.50233047 |
| 191 | macrophage differentiation (GO:0030225) | 2.49999282 |
| 192 | monocyte chemotaxis (GO:0002548) | 2.49792655 |
| 193 | B cell mediated immunity (GO:0019724) | 2.49369188 |
| 194 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.49161313 |
| 195 | regulation of monocyte chemotaxis (GO:0090025) | 2.48966246 |
| 196 | detection of biotic stimulus (GO:0009595) | 2.48559312 |
| 197 | positive regulation of interleukin-6 production (GO:0032755) | 2.46987461 |
| 198 | mature B cell differentiation involved in immune response (GO:0002313) | 2.46739450 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 8.15458996 |
| 2 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 5.71510167 |
| 3 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 5.02874610 |
| 4 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 4.88409215 |
| 5 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 4.34957536 |
| 6 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.99109564 |
| 7 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.85107427 |
| 8 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.79070484 |
| 9 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.57787969 |
| 10 | GATA1_22025678_ChIP-Seq_K562_Human | 3.17995387 |
| 11 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.04154673 |
| 12 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.86237329 |
| 13 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.33962524 |
| 14 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.23191089 |
| 15 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.21941949 |
| 16 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.18685824 |
| 17 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.18216386 |
| 18 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.10082788 |
| 19 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.09796093 |
| 20 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.06304201 |
| 21 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.02288176 |
| 22 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.94493898 |
| 23 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.93198969 |
| 24 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.92565737 |
| 25 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.91014566 |
| 26 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.78535141 |
| 27 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.77171909 |
| 28 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.72443433 |
| 29 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.71168998 |
| 30 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.64196904 |
| 31 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.63217503 |
| 32 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.62094688 |
| 33 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.61987180 |
| 34 | * EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.60792394 |
| 35 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.48649652 |
| 36 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.47727816 |
| 37 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.44848454 |
| 38 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.39898913 |
| 39 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.36977488 |
| 40 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.36200699 |
| 41 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.34658872 |
| 42 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.32084342 |
| 43 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.30471174 |
| 44 | GATA1_19941826_ChIP-Seq_K562_Human | 1.29589973 |
| 45 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.29573630 |
| 46 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.28409564 |
| 47 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.27857791 |
| 48 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.26733950 |
| 49 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.26655171 |
| 50 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.24992527 |
| 51 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.24357795 |
| 52 | MYC_22102868_ChIP-Seq_BL_Human | 1.23191503 |
| 53 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.21171817 |
| 54 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.20052629 |
| 55 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.18993550 |
| 56 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.18370270 |
| 57 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.17406884 |
| 58 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.15499934 |
| 59 | * LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.15083276 |
| 60 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.13052017 |
| 61 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.12772490 |
| 62 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.11390535 |
| 63 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.10418477 |
| 64 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.09656739 |
| 65 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.08745799 |
| 66 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.08671388 |
| 67 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.05792634 |
| 68 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.05482451 |
| 69 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 1.04653757 |
| 70 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.01560550 |
| 71 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.00428635 |
| 72 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.00249071 |
| 73 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.00102721 |
| 74 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.99272769 |
| 75 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.99223394 |
| 76 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.98994971 |
| 77 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.98262693 |
| 78 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.97787663 |
| 79 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.97486261 |
| 80 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.97427876 |
| 81 | GATA2_19941826_ChIP-Seq_K562_Human | 0.96869268 |
| 82 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.96555309 |
| 83 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.95761630 |
| 84 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.94399686 |
| 85 | * PU_27001747_Chip-Seq_BMDM_Mouse | 0.93262570 |
| 86 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.92989460 |
| 87 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.92885907 |
| 88 | MAF_26560356_Chip-Seq_TH1_Human | 0.91898441 |
| 89 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.91783177 |
| 90 | * ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.89510266 |
| 91 | MAF_26560356_Chip-Seq_TH2_Human | 0.88994731 |
| 92 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.88919588 |
| 93 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.87168426 |
| 94 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.86906584 |
| 95 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.86516801 |
| 96 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.86342876 |
| 97 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.85082798 |
| 98 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.84478940 |
| 99 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.83498071 |
| 100 | MYB_26560356_Chip-Seq_TH1_Human | 0.82978168 |
| 101 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 0.82870244 |
| 102 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.80106976 |
| 103 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.79457010 |
| 104 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 0.79194836 |
| 105 | MYB_26560356_Chip-Seq_TH2_Human | 0.78772783 |
| 106 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.78537843 |
| 107 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.78445289 |
| 108 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.78318643 |
| 109 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.77372635 |
| 110 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.76667365 |
| 111 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.76599454 |
| 112 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.75804781 |
| 113 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.75141533 |
| 114 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 0.73625446 |
| 115 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.73359338 |
| 116 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.72099893 |
| 117 | SPI1_23127762_ChIP-Seq_K562_Human | 0.71839012 |
| 118 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.71469545 |
| 119 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.70268572 |
| 120 | UTX_26944678_Chip-Seq_JUKART_Human | 0.68474603 |
| 121 | * HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.68073500 |
| 122 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.67902307 |
| 123 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.67784200 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 5.87299561 |
| 2 | MP0005360_urolithiasis | 5.06006575 |
| 3 | MP0005365_abnormal_bile_salt | 4.44874891 |
| 4 | MP0005085_abnormal_gallbladder_physiolo | 4.40097957 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 3.67444328 |
| 6 | MP0009840_abnormal_foam_cell | 3.57427090 |
| 7 | MP0003806_abnormal_nucleotide_metabolis | 3.08917452 |
| 8 | MP0005083_abnormal_biliary_tract | 2.93774492 |
| 9 | MP0003191_abnormal_cellular_cholesterol | 2.89217769 |
| 10 | MP0010329_abnormal_lipoprotein_level | 2.84706834 |
| 11 | MP0003656_abnormal_erythrocyte_physiolo | 2.78960771 |
| 12 | MP0003252_abnormal_bile_duct | 2.77652151 |
| 13 | MP0005058_abnormal_lysosome_morphology | 2.40191635 |
| 14 | MP0003195_calcinosis | 2.39865772 |
| 15 | MP0003436_decreased_susceptibility_to | 2.04250464 |
| 16 | MP0001666_abnormal_nutrient_absorption | 2.02686789 |
| 17 | MP0009278_abnormal_bone_marrow | 2.01929371 |
| 18 | MP0000609_abnormal_liver_physiology | 2.01051382 |
| 19 | MP0005332_abnormal_amino_acid | 1.98263457 |
| 20 | MP0003186_abnormal_redox_activity | 1.89731740 |
| 21 | MP0002138_abnormal_hepatobiliary_system | 1.87249806 |
| 22 | MP0001835_abnormal_antigen_presentation | 1.85894413 |
| 23 | MP0008004_abnormal_stomach_pH | 1.83689010 |
| 24 | MP0005319_abnormal_enzyme/_coenzyme | 1.78945529 |
| 25 | MP0006082_CNS_inflammation | 1.74265604 |
| 26 | MP0003453_abnormal_keratinocyte_physiol | 1.73293591 |
| 27 | MP0005464_abnormal_platelet_physiology | 1.72005634 |
| 28 | MP0002118_abnormal_lipid_homeostasis | 1.69900527 |
| 29 | MP0003724_increased_susceptibility_to | 1.66687052 |
| 30 | MP0002998_abnormal_bone_remodeling | 1.61290210 |
| 31 | MP0002419_abnormal_innate_immunity | 1.57064222 |
| 32 | MP0009764_decreased_sensitivity_to | 1.55923876 |
| 33 | MP0008469_abnormal_protein_level | 1.53677531 |
| 34 | MP0003172_abnormal_lysosome_physiology | 1.50776381 |
| 35 | MP0004019_abnormal_vitamin_homeostasis | 1.50453016 |
| 36 | MP0009785_altered_susceptibility_to | 1.50273008 |
| 37 | MP0003303_peritoneal_inflammation | 1.45145652 |
| 38 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.44997482 |
| 39 | MP0000858_altered_metastatic_potential | 1.41312680 |
| 40 | MP0004147_increased_porphyrin_level | 1.41300031 |
| 41 | MP0005025_abnormal_response_to | 1.39019108 |
| 42 | MP0009643_abnormal_urine_homeostasis | 1.37495037 |
| 43 | MP0001764_abnormal_homeostasis | 1.37124984 |
| 44 | MP0003868_abnormal_feces_composition | 1.32533278 |
| 45 | MP0003448_altered_tumor_morphology | 1.29549026 |
| 46 | MP0000604_amyloidosis | 1.28773133 |
| 47 | MP0000598_abnormal_liver_morphology | 1.27638242 |
| 48 | MP0003828_pulmonary_edema | 1.26931304 |
| 49 | MP0009763_increased_sensitivity_to | 1.24078918 |
| 50 | MP0001853_heart_inflammation | 1.21309585 |
| 51 | MP0003011_delayed_dark_adaptation | 1.21152021 |
| 52 | MP0008260_abnormal_autophagy | 1.19121507 |
| 53 | MP0000685_abnormal_immune_system | 1.16806364 |
| 54 | MP0003300_gastrointestinal_ulcer | 1.14682305 |
| 55 | MP0005000_abnormal_immune_tolerance | 1.14030094 |
| 56 | MP0005310_abnormal_salivary_gland | 1.13612329 |
| 57 | MP0001845_abnormal_inflammatory_respons | 1.13016663 |
| 58 | MP0005636_abnormal_mineral_homeostasis | 1.09559739 |
| 59 | MP0002148_abnormal_hypersensitivity_rea | 1.05977686 |
| 60 | MP0003329_amyloid_beta_deposits | 1.05761939 |
| 61 | MP0005165_increased_susceptibility_to | 1.05324618 |
| 62 | MP0005397_hematopoietic_system_phenotyp | 1.01563821 |
| 63 | MP0001545_abnormal_hematopoietic_system | 1.01563821 |
| 64 | MP0006054_spinal_hemorrhage | 1.00981829 |
| 65 | MP0006036_abnormal_mitochondrial_physio | 0.99440968 |
| 66 | MP0002452_abnormal_antigen_presenting | 0.99169968 |
| 67 | MP0001533_abnormal_skeleton_physiology | 0.98404244 |
| 68 | MP0003075_altered_response_to | 0.97979259 |
| 69 | MP0005387_immune_system_phenotype | 0.97822715 |
| 70 | MP0001790_abnormal_immune_system | 0.97822715 |
| 71 | MP0004130_abnormal_muscle_cell | 0.97594490 |
| 72 | MP0010234_abnormal_vibrissa_follicle | 0.97392754 |
| 73 | MP0002723_abnormal_immune_serum | 0.96078120 |
| 74 | MP0000343_altered_response_to | 0.96067337 |
| 75 | MP0009697_abnormal_copulation | 0.95790394 |
| 76 | MP0004947_skin_inflammation | 0.94412240 |
| 77 | MP0001851_eye_inflammation | 0.94030088 |
| 78 | MP0001800_abnormal_humoral_immune | 0.93732589 |
| 79 | MP0005451_abnormal_body_composition | 0.92744594 |
| 80 | MP0003183_abnormal_peptide_metabolism | 0.92002879 |
| 81 | MP0002796_impaired_skin_barrier | 0.91835039 |
| 82 | MP0002254_reproductive_system_inflammat | 0.90189694 |
| 83 | MP0009642_abnormal_blood_homeostasis | 0.89970141 |
| 84 | MP0003705_abnormal_hypodermis_morpholog | 0.89706058 |
| 85 | MP0005671_abnormal_response_to | 0.89110774 |
| 86 | MP0000920_abnormal_myelination | 0.88968402 |
| 87 | MP0003690_abnormal_glial_cell | 0.88600182 |
| 88 | MP0002398_abnormal_bone_marrow | 0.87653978 |
| 89 | MP0004782_abnormal_surfactant_physiolog | 0.86052704 |
| 90 | MP0005670_abnormal_white_adipose | 0.82630557 |
| 91 | MP0005666_abnormal_adipose_tissue | 0.82270656 |
| 92 | MP0002332_abnormal_exercise_endurance | 0.81873059 |
| 93 | MP0004883_abnormal_blood_vessel | 0.80986682 |
| 94 | MP0005166_decreased_susceptibility_to | 0.79348823 |
| 95 | MP0001819_abnormal_immune_cell | 0.77449009 |
| 96 | MP0002420_abnormal_adaptive_immunity | 0.76803246 |
| 97 | MP0004808_abnormal_hematopoietic_stem | 0.76236757 |
| 98 | MP0009765_abnormal_xenobiotic_induced | 0.75950268 |
| 99 | MP0001756_abnormal_urination | 0.75794311 |
| 100 | MP0002166_altered_tumor_susceptibility | 0.75616824 |
| 101 | MP0002078_abnormal_glucose_homeostasis | 0.75503657 |
| 102 | MP0003795_abnormal_bone_structure | 0.75420467 |
| 103 | MP0002971_abnormal_brown_adipose | 0.75416154 |
| 104 | MP0005334_abnormal_fat_pad | 0.74825564 |
| 105 | MP0010155_abnormal_intestine_physiology | 0.74703529 |
| 106 | MP0005220_abnormal_exocrine_pancreas | 0.74507942 |
| 107 | MP0002722_abnormal_immune_system | 0.74331713 |
| 108 | MP0000689_abnormal_spleen_morphology | 0.73903891 |
| 109 | MP0005390_skeleton_phenotype | 0.73463608 |
| 110 | MP0005376_homeostasis/metabolism_phenot | 0.72816380 |
| 111 | MP0002136_abnormal_kidney_physiology | 0.72420714 |
| 112 | MP0005023_abnormal_wound_healing | 0.72338330 |
| 113 | MP0008874_decreased_physiological_sensi | 0.71961578 |
| 114 | MP0002405_respiratory_system_inflammati | 0.71678730 |
| 115 | MP0005647_abnormal_sex_gland | 0.68268343 |
| 116 | MP0001216_abnormal_epidermal_layer | 0.67821017 |
| 117 | MP0000465_gastrointestinal_hemorrhage | 0.67312081 |
| 118 | MP0001542_abnormal_bone_strength | 0.67004758 |
| 119 | MP0005408_hypopigmentation | 0.66854490 |
| 120 | MP0004185_abnormal_adipocyte_glucose | 0.66751689 |
| 121 | MP0004510_myositis | 0.65484326 |
| 122 | MP0005167_abnormal_blood-brain_barrier | 0.65396985 |
| 123 | MP0008873_increased_physiological_sensi | 0.64396855 |
| 124 | MP0003091_abnormal_cell_migration | 0.63523521 |
| 125 | MP0005164_abnormal_response_to | 0.63230581 |
| 126 | MP0000716_abnormal_immune_system | 0.62741194 |
| 127 | MP0010307_abnormal_tumor_latency | 0.62257066 |
| 128 | MP0000249_abnormal_blood_vessel | 0.61656561 |
| 129 | MP0002429_abnormal_blood_cell | 0.61607781 |
| 130 | MP0009333_abnormal_splenocyte_physiolog | 0.61455538 |
| 131 | MP0005535_abnormal_body_temperature | 0.60907123 |
| 132 | MP0002877_abnormal_melanocyte_morpholog | 0.60167885 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of glycolipid metabolism (HP:0010969) | 7.33162526 |
| 2 | Abnormality of liposaccharide metabolism (HP:0010968) | 7.33162526 |
| 3 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 7.33162526 |
| 4 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 5.30375217 |
| 5 | Intrahepatic cholestasis (HP:0001406) | 4.99935764 |
| 6 | Deep venous thrombosis (HP:0002625) | 4.90954558 |
| 7 | Xanthomatosis (HP:0000991) | 4.87818798 |
| 8 | Prolonged partial thromboplastin time (HP:0003645) | 4.70971773 |
| 9 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 4.65972582 |
| 10 | Hyperlipoproteinemia (HP:0010980) | 4.39019094 |
| 11 | Complement deficiency (HP:0004431) | 4.22313917 |
| 12 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.21964167 |
| 13 | Joint hemorrhage (HP:0005261) | 4.14840255 |
| 14 | Hypobetalipoproteinemia (HP:0003563) | 4.11938848 |
| 15 | Loss of speech (HP:0002371) | 4.05872888 |
| 16 | Disinhibition (HP:0000734) | 3.99905711 |
| 17 | Abnormality of the common coagulation pathway (HP:0010990) | 3.65867237 |
| 18 | Systemic lupus erythematosus (HP:0002725) | 3.58337155 |
| 19 | Hypoglycemic coma (HP:0001325) | 3.36571256 |
| 20 | Hypolipoproteinemia (HP:0010981) | 3.35950638 |
| 21 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.32950262 |
| 22 | Vacuolated lymphocytes (HP:0001922) | 3.32866416 |
| 23 | Abnormality of complement system (HP:0005339) | 3.31869297 |
| 24 | Hyperammonemia (HP:0001987) | 3.30922578 |
| 25 | Epidermoid cyst (HP:0200040) | 3.29705828 |
| 26 | Hypercholesterolemia (HP:0003124) | 3.26359245 |
| 27 | Abnormality of the intrinsic pathway (HP:0010989) | 3.22420430 |
| 28 | Mutism (HP:0002300) | 3.21737190 |
| 29 | Hypoalphalipoproteinemia (HP:0003233) | 3.17503855 |
| 30 | Hyperbilirubinemia (HP:0002904) | 3.17049576 |
| 31 | Myocardial infarction (HP:0001658) | 3.16855859 |
| 32 | Recurrent bacterial skin infections (HP:0005406) | 3.14867273 |
| 33 | Fat malabsorption (HP:0002630) | 3.12886929 |
| 34 | Neurofibrillary tangles (HP:0002185) | 3.10636246 |
| 35 | Ketosis (HP:0001946) | 3.05282291 |
| 36 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.02149941 |
| 37 | Increased cerebral lipofuscin (HP:0011813) | 3.00430556 |
| 38 | Eczematoid dermatitis (HP:0000976) | 2.98152606 |
| 39 | Poikilocytosis (HP:0004447) | 2.98132713 |
| 40 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.97281904 |
| 41 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.89228500 |
| 42 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.87984281 |
| 43 | Abnormality of methionine metabolism (HP:0010901) | 2.86418874 |
| 44 | Acanthocytosis (HP:0001927) | 2.85771190 |
| 45 | Glomerulonephritis (HP:0000099) | 2.85431128 |
| 46 | Recurrent abscess formation (HP:0002722) | 2.79820382 |
| 47 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.76301293 |
| 48 | Orchitis (HP:0100796) | 2.75941684 |
| 49 | Mediastinal lymphadenopathy (HP:0100721) | 2.75291007 |
| 50 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.72887485 |
| 51 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.71476386 |
| 52 | Myositis (HP:0100614) | 2.71258885 |
| 53 | Hyperglycinemia (HP:0002154) | 2.70426346 |
| 54 | Nuclear cataract (HP:0100018) | 2.69026716 |
| 55 | Gingival bleeding (HP:0000225) | 2.67562798 |
| 56 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.64219223 |
| 57 | Axonal loss (HP:0003447) | 2.60609139 |
| 58 | Mucopolysacchariduria (HP:0008155) | 2.60114985 |
| 59 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.60114985 |
| 60 | Nausea (HP:0002018) | 2.60107141 |
| 61 | Abnormality of iron homeostasis (HP:0011031) | 2.58010727 |
| 62 | Hepatocellular carcinoma (HP:0001402) | 2.57286969 |
| 63 | Hepatosplenomegaly (HP:0001433) | 2.56719700 |
| 64 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.56671856 |
| 65 | Steatorrhea (HP:0002570) | 2.55399177 |
| 66 | Spontaneous hematomas (HP:0007420) | 2.54110996 |
| 67 | Abnormality of macrophages (HP:0004311) | 2.53651453 |
| 68 | Dysostosis multiplex (HP:0000943) | 2.53379424 |
| 69 | Conjugated hyperbilirubinemia (HP:0002908) | 2.52750128 |
| 70 | Hyperglycinuria (HP:0003108) | 2.50211997 |
| 71 | Chronic obstructive pulmonary disease (HP:0006510) | 2.49402698 |
| 72 | Obstructive lung disease (HP:0006536) | 2.49402698 |
| 73 | Menorrhagia (HP:0000132) | 2.48536879 |
| 74 | Retrobulbar optic neuritis (HP:0100654) | 2.48130669 |
| 75 | Optic neuritis (HP:0100653) | 2.48130669 |
| 76 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.47809286 |
| 77 | Increased serum ferritin (HP:0003281) | 2.43207974 |
| 78 | Diminished motivation (HP:0000745) | 2.41930390 |
| 79 | Abnormality of nucleobase metabolism (HP:0010932) | 2.41543931 |
| 80 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.41338301 |
| 81 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.41338301 |
| 82 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.41338301 |
| 83 | Progressive neurologic deterioration (HP:0002344) | 2.40690977 |
| 84 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.39954728 |
| 85 | Abnormality of glycine metabolism (HP:0010895) | 2.39954728 |
| 86 | Cholelithiasis (HP:0001081) | 2.39308853 |
| 87 | Cerebral inclusion bodies (HP:0100314) | 2.39139050 |
| 88 | Apathy (HP:0000741) | 2.38895714 |
| 89 | Abnormal gallbladder morphology (HP:0012437) | 2.35771584 |
| 90 | Abnormality of purine metabolism (HP:0004352) | 2.33979969 |
| 91 | Generalized aminoaciduria (HP:0002909) | 2.33162438 |
| 92 | Reticulocytosis (HP:0001923) | 2.32141367 |
| 93 | Epistaxis (HP:0000421) | 2.31026821 |
| 94 | Hypochromic microcytic anemia (HP:0004840) | 2.29228951 |
| 95 | Skin nodule (HP:0200036) | 2.29105915 |
| 96 | Esophageal varix (HP:0002040) | 2.28948755 |
| 97 | Ketoacidosis (HP:0001993) | 2.28638398 |
| 98 | Upper motor neuron abnormality (HP:0002127) | 2.28400954 |
| 99 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.27738238 |
| 100 | Neuronal loss in central nervous system (HP:0002529) | 2.25641877 |
| 101 | Dicarboxylic aciduria (HP:0003215) | 2.23453045 |
| 102 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.23453045 |
| 103 | Polycythemia (HP:0001901) | 2.18829846 |
| 104 | Asymmetric septal hypertrophy (HP:0001670) | 2.18554219 |
| 105 | Impaired platelet aggregation (HP:0003540) | 2.17741990 |
| 106 | Abnormal platelet function (HP:0011869) | 2.17741990 |
| 107 | Stomatitis (HP:0010280) | 2.17650098 |
| 108 | Thoracic kyphosis (HP:0002942) | 2.16715933 |
| 109 | Amyloidosis (HP:0011034) | 2.15579982 |
| 110 | Autoimmune thrombocytopenia (HP:0001973) | 2.15018756 |
| 111 | Metabolic acidosis (HP:0001942) | 2.14962499 |
| 112 | Urticaria (HP:0001025) | 2.14640648 |
| 113 | Vertebral compression fractures (HP:0002953) | 2.12806357 |
| 114 | Recurrent skin infections (HP:0001581) | 2.11926975 |
| 115 | Interstitial pulmonary disease (HP:0006530) | 2.11611809 |
| 116 | Increased IgE level (HP:0003212) | 2.11317460 |
| 117 | Thrombophlebitis (HP:0004418) | 2.10951790 |
| 118 | Gingivitis (HP:0000230) | 2.10533044 |
| 119 | Tetraparesis (HP:0002273) | 2.09120335 |
| 120 | Microcytic anemia (HP:0001935) | 2.07142340 |
| 121 | Purpura (HP:0000979) | 2.06850160 |
| 122 | Agnosia (HP:0010524) | 2.04993774 |
| 123 | Hypoglycemic seizures (HP:0002173) | 2.04014208 |
| 124 | Personality changes (HP:0000751) | 2.03378829 |
| 125 | Hematochezia (HP:0002573) | 2.03129783 |
| 126 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.02592351 |
| 127 | Cardiomegaly (HP:0001640) | 1.98852163 |
| 128 | Petechiae (HP:0000967) | 1.98785018 |
| 129 | Bone pain (HP:0002653) | 1.98474002 |
| 130 | Keratoconjunctivitis sicca (HP:0001097) | 1.98208531 |
| 131 | Pancreatitis (HP:0001733) | 1.97551485 |
| 132 | Late onset (HP:0003584) | 1.97005734 |
| 133 | Metaphyseal irregularity (HP:0003025) | 1.96655612 |
| 134 | Sensorimotor neuropathy (HP:0007141) | 1.96523668 |
| 135 | Gangrene (HP:0100758) | 1.96317476 |
| 136 | Delayed CNS myelination (HP:0002188) | 1.94946755 |
| 137 | Spastic diplegia (HP:0001264) | 1.94721191 |
| 138 | Abnormality of serum amino acid levels (HP:0003112) | 1.94493918 |
| 139 | Nephritis (HP:0000123) | 1.94332729 |
| 140 | Prolonged bleeding time (HP:0003010) | 1.94023035 |
| 141 | Pulmonary infiltrates (HP:0002113) | 1.94013100 |
| 142 | Abnormality of the periventricular white matter (HP:0002518) | 1.93350319 |
| 143 | Inappropriate behavior (HP:0000719) | 1.93113779 |
| 144 | Dementia (HP:0000726) | 1.92411342 |
| 145 | Conjunctival telangiectasia (HP:0000524) | 1.89818374 |
| 146 | Pathologic fracture (HP:0002756) | 1.89478185 |
| 147 | Prolonged neonatal jaundice (HP:0006579) | 1.80621403 |
| 148 | Hypertensive crisis (HP:0100735) | 1.78389670 |
| 149 | Hemoptysis (HP:0002105) | 1.77456112 |
| 150 | Peripheral demyelination (HP:0011096) | 1.77398757 |
| 151 | Paralysis (HP:0003470) | 1.77367606 |
| 152 | Basal ganglia calcification (HP:0002135) | 1.75821404 |
| 153 | Polyneuropathy (HP:0001271) | 1.75274227 |
| 154 | Recurrent viral infections (HP:0004429) | 1.74468892 |
| 155 | Vasculitis (HP:0002633) | 1.74426452 |
| 156 | Malnutrition (HP:0004395) | 1.74078693 |
| 157 | Keratoconjunctivitis (HP:0001096) | 1.70380813 |
| 158 | Gastrointestinal infarctions (HP:0005244) | 1.69893393 |
| 159 | Abnormality of the lumbar spine (HP:0100712) | 1.69507200 |
| 160 | Recurrent fungal infections (HP:0002841) | 1.69196649 |
| 161 | J-shaped sella turcica (HP:0002680) | 1.69075702 |
| 162 | Hypergammaglobulinemia (HP:0010702) | 1.64616342 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ERN1 | 4.30674826 |
| 2 | TAOK3 | 3.78047820 |
| 3 | BCKDK | 3.55386697 |
| 4 | TBK1 | 2.80492178 |
| 5 | PRPF4B | 2.67898765 |
| 6 | TAOK2 | 2.53668491 |
| 7 | TYK2 | 2.51157721 |
| 8 | NME2 | 2.47775567 |
| 9 | GRK7 | 2.38846705 |
| 10 | IRAK3 | 2.26404086 |
| 11 | KIT | 2.19315275 |
| 12 | FGFR4 | 2.13839698 |
| 13 | PKN2 | 2.12931196 |
| 14 | TRIB3 | 2.12343658 |
| 15 | FLT3 | 2.11242809 |
| 16 | TGFBR2 | 2.02950457 |
| 17 | PBK | 2.00054225 |
| 18 | BLK | 1.98551978 |
| 19 | DDR2 | 1.93082976 |
| 20 | MAP2K3 | 1.92250600 |
| 21 | IRAK4 | 1.83864556 |
| 22 | MAP4K1 | 1.81278478 |
| 23 | SIK1 | 1.75558671 |
| 24 | NEK9 | 1.70433894 |
| 25 | MAP3K14 | 1.69006142 |
| 26 | TAOK1 | 1.64215847 |
| 27 | IKBKE | 1.63924660 |
| 28 | ABL2 | 1.62041840 |
| 29 | FGR | 1.59451849 |
| 30 | BMPR2 | 1.57614903 |
| 31 | INSRR | 1.49701525 |
| 32 | ZAP70 | 1.47432038 |
| 33 | JAK2 | 1.41288978 |
| 34 | KDR | 1.40992697 |
| 35 | MST1R | 1.39875161 |
| 36 | JAK3 | 1.38137240 |
| 37 | SCYL2 | 1.35820335 |
| 38 | JAK1 | 1.34217452 |
| 39 | PIM2 | 1.33497146 |
| 40 | RIPK4 | 1.32436249 |
| 41 | BTK | 1.32413537 |
| 42 | MOS | 1.31550232 |
| 43 | CSF1R | 1.31483542 |
| 44 | MAP3K3 | 1.28998295 |
| 45 | MAP3K11 | 1.23738303 |
| 46 | PIK3CG | 1.18769502 |
| 47 | TEC | 1.18330973 |
| 48 | EIF2AK1 | 1.17583124 |
| 49 | IKBKB | 1.17203642 |
| 50 | MAPK11 | 1.17173293 |
| 51 | PTK6 | 1.12866971 |
| 52 | STK4 | 1.08863023 |
| 53 | CDC42BPA | 1.04654183 |
| 54 | SYK | 1.04137232 |
| 55 | ARAF | 0.96057478 |
| 56 | LRRK2 | 0.93282799 |
| 57 | MAP3K6 | 0.91547099 |
| 58 | EPHB1 | 0.91081222 |
| 59 | RPS6KA4 | 0.89646401 |
| 60 | PIM1 | 0.89564854 |
| 61 | TESK2 | 0.89289358 |
| 62 | KSR2 | 0.89264321 |
| 63 | LYN | 0.88709868 |
| 64 | TESK1 | 0.87829830 |
| 65 | CSK | 0.86421870 |
| 66 | FES | 0.85831394 |
| 67 | CDK6 | 0.84901010 |
| 68 | ACVR1B | 0.83145049 |
| 69 | IRAK2 | 0.81000755 |
| 70 | MATK | 0.78292642 |
| 71 | MAP3K10 | 0.78061981 |
| 72 | CLK1 | 0.76458872 |
| 73 | MAPKAPK3 | 0.73724129 |
| 74 | CAMK1D | 0.72235418 |
| 75 | MAP3K5 | 0.71052884 |
| 76 | TIE1 | 0.70482565 |
| 77 | GRK6 | 0.69127197 |
| 78 | STK10 | 0.68881985 |
| 79 | ERBB4 | 0.68100041 |
| 80 | MAP3K1 | 0.67095732 |
| 81 | IRAK1 | 0.66200065 |
| 82 | DYRK1B | 0.65764540 |
| 83 | RIPK1 | 0.63592162 |
| 84 | PAK4 | 0.61650956 |
| 85 | MAP3K2 | 0.60168873 |
| 86 | EIF2AK3 | 0.59670133 |
| 87 | MAP2K6 | 0.59508506 |
| 88 | HCK | 0.59129662 |
| 89 | LCK | 0.58400190 |
| 90 | MAPK4 | 0.55405535 |
| 91 | RPS6KL1 | 0.55334444 |
| 92 | RPS6KC1 | 0.55334444 |
| 93 | EGFR | 0.54711557 |
| 94 | PDGFRA | 0.54008912 |
| 95 | ITK | 0.53209111 |
| 96 | PDK2 | 0.51854883 |
| 97 | DYRK3 | 0.51452674 |
| 98 | PRKAA2 | 0.51008145 |
| 99 | PRKCD | 0.50678871 |
| 100 | STK16 | 0.50154483 |
| 101 | CAMKK2 | 0.49741666 |
| 102 | CHUK | 0.49109289 |
| 103 | ABL1 | 0.49089966 |
| 104 | EPHA3 | 0.46773577 |
| 105 | TRPM7 | 0.44551684 |
| 106 | SIK3 | 0.44442321 |
| 107 | ICK | 0.44222185 |
| 108 | PDPK1 | 0.42605038 |
| 109 | MARK3 | 0.42169751 |
| 110 | ADRBK2 | 0.41628785 |
| 111 | CDK4 | 0.40323937 |
| 112 | BMX | 0.39922977 |
| 113 | PRKG2 | 0.37548786 |
| 114 | MAPK15 | 0.37419481 |
| 115 | ERBB2 | 0.37359457 |
| 116 | RPS6KA6 | 0.37053056 |
| 117 | MAP3K8 | 0.36675756 |
| 118 | MAP3K13 | 0.36666688 |
| 119 | MAPK12 | 0.36464154 |
| 120 | TGFBR1 | 0.36426070 |
| 121 | TXK | 0.36367263 |
| 122 | RAF1 | 0.35807748 |
| 123 | MAPKAPK2 | 0.35112192 |
| 124 | RPS6KA2 | 0.34929408 |
| 125 | HIPK2 | 0.34723849 |
| 126 | PRKACG | 0.34206646 |
| 127 | IGF1R | 0.34204804 |
| 128 | LATS2 | 0.34116859 |
| 129 | TLK1 | 0.32712905 |
| 130 | MAP2K2 | 0.32651786 |
| 131 | PDK1 | 0.31783851 |
| 132 | EEF2K | 0.31446026 |
| 133 | GSK3A | 0.31404293 |
| 134 | FGFR3 | 0.31249259 |
| 135 | BRSK2 | 0.30859061 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.06855161 |
| 2 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.18981660 |
| 3 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.90795781 |
| 4 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.84551462 |
| 5 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.69030064 |
| 6 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.63800620 |
| 7 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.56559127 |
| 8 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.50885057 |
| 9 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.50632567 |
| 10 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.40224415 |
| 11 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.37449576 |
| 12 | Asthma_Homo sapiens_hsa05310 | 2.33969139 |
| 13 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.25938604 |
| 14 | Allograft rejection_Homo sapiens_hsa05330 | 2.10918744 |
| 15 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.09911391 |
| 16 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.09840518 |
| 17 | Peroxisome_Homo sapiens_hsa04146 | 2.05943462 |
| 18 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.04640082 |
| 19 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 2.04018028 |
| 20 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.02288915 |
| 21 | Histidine metabolism_Homo sapiens_hsa00340 | 1.85813589 |
| 22 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.83140654 |
| 23 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.81035877 |
| 24 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.78670654 |
| 25 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.72240554 |
| 26 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.70409107 |
| 27 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.70122028 |
| 28 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.69365143 |
| 29 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.65154852 |
| 30 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.63598187 |
| 31 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.62568707 |
| 32 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.62302831 |
| 33 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.61568151 |
| 34 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.60792870 |
| 35 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.59094945 |
| 36 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.56496247 |
| 37 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.55065508 |
| 38 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.52675878 |
| 39 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.49688756 |
| 40 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.48593807 |
| 41 | Retinol metabolism_Homo sapiens_hsa00830 | 1.44820526 |
| 42 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.43070342 |
| 43 | ABC transporters_Homo sapiens_hsa02010 | 1.41649461 |
| 44 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.40293041 |
| 45 | Salmonella infection_Homo sapiens_hsa05132 | 1.39858805 |
| 46 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.34511288 |
| 47 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.33662786 |
| 48 | Sulfur relay system_Homo sapiens_hsa04122 | 1.31129919 |
| 49 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.28492681 |
| 50 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.28167059 |
| 51 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.25435778 |
| 52 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.24954857 |
| 53 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.23850620 |
| 54 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.23635197 |
| 55 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.20907785 |
| 56 | Bile secretion_Homo sapiens_hsa04976 | 1.16259536 |
| 57 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.16197220 |
| 58 | Lysosome_Homo sapiens_hsa04142 | 1.15585760 |
| 59 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.12654686 |
| 60 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.12560319 |
| 61 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.11331606 |
| 62 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.09881557 |
| 63 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.07809368 |
| 64 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.05761672 |
| 65 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.05675504 |
| 66 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.04454018 |
| 67 | Other glycan degradation_Homo sapiens_hsa00511 | 1.02831515 |
| 68 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.01964182 |
| 69 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.01033508 |
| 70 | Carbon metabolism_Homo sapiens_hsa01200 | 0.99586290 |
| 71 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.99257967 |
| 72 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.98378457 |
| 73 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.97607749 |
| 74 | Viral myocarditis_Homo sapiens_hsa05416 | 0.95714133 |
| 75 | Amoebiasis_Homo sapiens_hsa05146 | 0.95357823 |
| 76 | Hepatitis C_Homo sapiens_hsa05160 | 0.94617272 |
| 77 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.94604709 |
| 78 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.93331896 |
| 79 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.92799393 |
| 80 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.92493197 |
| 81 | Bladder cancer_Homo sapiens_hsa05219 | 0.91513580 |
| 82 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.89704648 |
| 83 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.89197253 |
| 84 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.89115543 |
| 85 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.86352152 |
| 86 | Shigellosis_Homo sapiens_hsa05131 | 0.86212365 |
| 87 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.84015012 |
| 88 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.83197666 |
| 89 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.79376180 |
| 90 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.74081055 |
| 91 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.73614524 |
| 92 | Hepatitis B_Homo sapiens_hsa05161 | 0.72689422 |
| 93 | Mineral absorption_Homo sapiens_hsa04978 | 0.70269445 |
| 94 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.69806254 |
| 95 | Leishmaniasis_Homo sapiens_hsa05140 | 0.69651760 |
| 96 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.67075796 |
| 97 | Galactose metabolism_Homo sapiens_hsa00052 | 0.66439521 |
| 98 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.65736541 |
| 99 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.63650939 |
| 100 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.63164037 |
| 101 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.61962872 |
| 102 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.61123156 |
| 103 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.60918402 |
| 104 | Legionellosis_Homo sapiens_hsa05134 | 0.60486654 |
| 105 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.59063867 |
| 106 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.59013162 |
| 107 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.58688511 |
| 108 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.58393550 |
| 109 | Platelet activation_Homo sapiens_hsa04611 | 0.55977443 |
| 110 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.54989453 |
| 111 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.51712739 |
| 112 | Lysine degradation_Homo sapiens_hsa00310 | 0.51516658 |
| 113 | Pertussis_Homo sapiens_hsa05133 | 0.51373108 |
| 114 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.50973142 |
| 115 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.50848409 |
| 116 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.50702594 |
| 117 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.49684353 |
| 118 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.47559017 |
| 119 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.46999401 |
| 120 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.46863457 |
| 121 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.45408325 |
| 122 | Malaria_Homo sapiens_hsa05144 | 0.45079761 |
| 123 | Metabolic pathways_Homo sapiens_hsa01100 | 0.44037430 |
| 124 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.43918288 |
| 125 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.40579413 |
| 126 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.40391430 |
| 127 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.39907136 |
| 128 | Insulin resistance_Homo sapiens_hsa04931 | 0.37943834 |
| 129 | Tuberculosis_Homo sapiens_hsa05152 | 0.37862383 |
| 130 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.37585831 |
| 131 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.37169774 |
| 132 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.35370696 |
| 133 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.34838310 |
| 134 | Prion diseases_Homo sapiens_hsa05020 | 0.34710565 |
| 135 | Phagosome_Homo sapiens_hsa04145 | 0.34422042 |
| 136 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.33345636 |
| 137 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.32915855 |
| 138 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.32673533 |
| 139 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.31893133 |
| 140 | Endocytosis_Homo sapiens_hsa04144 | 0.31641936 |
| 141 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.29743065 |
| 142 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.29253258 |
| 143 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.26449692 |
| 144 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.25673813 |
| 145 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.25000513 |
| 146 | Protein export_Homo sapiens_hsa03060 | 0.22746951 |
| 147 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.22052270 |
| 148 | Measles_Homo sapiens_hsa05162 | 0.22026573 |
| 149 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.19137985 |
| 150 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.19062105 |
| 151 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.19031500 |
| 152 | HTLV-I infection_Homo sapiens_hsa05166 | 0.18474913 |
| 153 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.17982529 |
| 154 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.17933175 |
| 155 | Influenza A_Homo sapiens_hsa05164 | 0.16856730 |
| 156 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.15899610 |
| 157 | Apoptosis_Homo sapiens_hsa04210 | 0.13813923 |

